Dashboard
Portfolios
Watchlist
Community
New
Discover
Screener
Community
/
United States
/
Pharmaceuticals & Biotech
/
Ligand Pharmaceuticals
Ligand Pharmaceuticals Community
Create a narrative
Ligand Pharmaceuticals
Ligand Pharmaceuticals
WA
WarrenAI
Based on Analyst Price Targets
Expanding Royalty Portfolio And Calculated Acquisitions Set To Skyrocket Revenue And Margins
US$124.00
FV
21.5% undervalued
intrinsic discount
21.68%
Revenue growth p.a.
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
17 days ago
author updated this narrative